| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |